Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CEE (Central and Eastern European) countries to join EU Research & Development programme:

This article was originally published in Clinica

Executive Summary

Cyprus and ten Central and Eastern European (CEE) countries have signed association agreements with the European Union giving researchers in those countries access to the EU's Fifth Framework Research Programme. The programme, which covers the period from 1999 to 2002, makes it easier for research institutes, universities and businesses to form partnerships and benefit from collaborative projects. The results of the first call for proposals showed strong interest from these countries, which in turn will open up their research programmes to scientists in the EU, the European Commission said. The countries, all of whom have applied for EU membership, are Bulgaria, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, the Slovak Republic and Slovenia.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079826

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel